Ibrutinib Versus Temsirolimus in Patients with Relapsed or Refractory Mantle-Cell Lymphoma: an International, Randomised, Open-Label, Phase Study

AuthID
P-00K-7CK
23
Author(s)
Dreyling, M
·
Jurczak, W
·
Jerkeman, M
·
Silva, RS
·
Rusconi, C
·
Offner, F
·
Caballero, D
·
Joao, C
·
[+3]·
Goldberg, JD
·
Enny, C
·
Traina, S
·
Balasubramanian, S
·
Bandyopadhyay, N
·
Sun, S
·
Vermeulen, J
·
Rizo, A
·
Tipo de Documento
Article
Year published
2016
Publicado
in LANCET, ISSN: 0140-6736
Volume: 387, Número: 10020, Páginas: 770-778 (9)
Indexing
Publication Identifiers
SCOPUS: 2-s2.0-84959074796
Wos: WOS:000370418000036
Source Identifiers
ISSN: 0140-6736
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.
Name Order Nome   Name Order Nome   Name Order Nome
1 Dreyling, M;   2 Jurczak, W;   3 Jerkeman, M;
4 Silva, RS;   5 Rusconi, C;   6 Trneny, M;
7 Offner, F;   8 Caballero, D;   9 Joao, C;
10 Witzens Harig, M;   11 Hess, G;   12 Bence Bruckler, I;
13 Cho, SG;   14 Bothos, J;   15 Goldberg, JD;
16 Enny, C;   17 Traina, S;   18 Balasubramanian, S;
19 Bandyopadhyay, N;   20 Sun, S;   21 Vermeulen, J;
22 Rizo, A;   23 Rule, S;